News & Events
News
A study by Sant Joan de Déu identifies the mechanisms that hinder the effectiveness of treatment for diffuse intrinsic pontine glioma in children
DIPG is an aggressive brain tumor that mainly affects pediatric patients and has a poor prognosis in all cases. The research team has identified two key proteins secreted by the tumor that suppress the immune system and promote the formation of barriers that hinder treatment.
Interviews
Manel González-Piñero
Headof Innovation at CREB UPC and XarTEC SALUT
"Our main objectives are to develop a technologies map of the members of XarTEC SALUT and to find the most effective ways to support them."
The Research Centre for Biomedical Engineering (CREB) at the UPC, an institution affiliated with the Institut de Recerca Sant Joan de Déu (IRSJD), received top funding in 2020 from the European Regional Development Fund (ERDF), under the management of the Government of Catalonia, to create and coordinate XarTEC SALUT, Catalonia's first health technologies innovation and valorisation network.Agenda
TECSAM | Regulació comparada: EUA i UE. Claus reguladores per a l'accés al mercat
Talyta Carteano, Medical Device Director a Asphalion.
Defensa tesi doctoral: Desiré Traver Edo
"Análisis de las necesidades a través de las experiencias de mujeres encarceladas desde una mirada del cuidado de la salud y bienestar mental"
Communications office
Marta Rodríguez i Natalia Giles
marta.rodriguezt(ELIMINAR)@sjd.es & natalia.giles(ELIMINAR)@sjd.es
936009751 Ext. 77858 - 81048